Evidence map›Paper›PMID 29912868›Full record

ArticlePloS one2018

The protective capacity of high payload FMDV A22 IRQ vaccine in sheep against direct-contact challenge with a heterologous, contemporary FMDV A strain from South East Asia.

Jacquelyn Horsington, Charles Nfon, Hilary Bittner, Peter A Durr, Nagendrakumar Singanallur, Soren Alexandersen, Wilna Vosloo

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jacquelyn HorsingtonAustralian Animal Health Laboratory, CSIRO, Geelong, Victoria, Australia.ORCID 0000-0001-7124-3104
Charles NfonNational Centres for Animal Disease, Canadian Food Inspection Agency, Winnipeg, Manitoba, Canada.
Hilary BittnerNational Centres for Animal Disease, Canadian Food Inspection Agency, Winnipeg, Manitoba, Canada.
Peter A DurrAustralian Animal Health Laboratory, CSIRO, Geelong, Victoria, Australia.
Nagendrakumar SinganallurAustralian Animal Health Laboratory, CSIRO, Geelong, Victoria, Australia.
Soren AlexandersenGeelong Centre for Emerging Infectious Diseases, Geelong, Victoria, Australia.
Wilna VoslooAustralian Animal Health Laboratory, CSIRO, Geelong, Victoria, Australia.
Commonwealth Scientific and Industrial Research Organisation · AUCanadian Food Inspection Agency · CABarwon Health · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Foot-and-mouth disease (FMD) is an acute, highly contagious viral disease of domestic and wild cloven-hoofed animals, caused by FMD virus (FMDV). An FMD outbreak can cause major production losses and have significant implications for trade. Vaccination can assist in controlling the disease, and emergency vaccination using high antigen payload vaccines (>6 PD50/dose) is considered an important control approach in the event of an outbreak. In recent years there has been a divergence of serotype A viruses in South East Asia (SEA) into several distinct genetic and antigenic clusters. Numerous variants were found to poorly match serotype A vaccines commonly included in international antigen banks. This study examined the ability of single vaccination with high-potency monovalent A22 IRQ vaccine to protect sheep following challenge with the A/VIT/15/2012 strain, just four days following vaccination. The vaccine proved effective at limiting clinical disease but did not prevent infection.

Indexed as

Foot-and-Mouth DiseaseSheepViral VaccinesAnimalsFoot-and-Mouth Disease VirusViral Vaccines

Identifiers

PMID29912868
PMCPMC6005461
OpenAlexW2809018417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.